Placeholder

iPharma Tirzepatide 30mg Self-Mix Vial

R1,800.00

Tirzepatide in a self-mix vial, studied for weight loss and blood-sugar control.

Description

iPharma Tirzepatide (a dual GIP/GLP-1 receptor agonist) supplied as a 30mg self-mix vial, researched for appetite regulation, weight management and blood-sugar control.